First-version generics predicted to exceed 30-70% of domestic pharmaceutical market

Published: 2004-08-30 07:00:00

Updated: 2004-08-30 07:00:00

Pharmaceutical business sources said that Korean first-version generic drugs, such as amlodipine and glimepiride, may make up more than 30 to 70 percent in less than 10 years, thanks to local doctors' changed perception in favor of Korean generics in terms of cheaper drug price and comparable eff...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK